share_log

維亞生物：截至二零二四年三月三十一日止月份股份發行人的證券變動月報表

VIVA BIOTECH: Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 March 2024

香港交易所 ·  Apr 2 22:37
Summary by Moomoo AI
维亚生物科技控股於2024年4月3日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的公司股本變動情況。報告顯示，公司的法定/註冊股本及已發行股份在過去一個月內均無變動，普通股股份數目維持在4,000,000,000股，每股面值0.000025美元，總法定/註冊股本為100,000美元。此外，公司的股份期權計劃中，首次公開發售前股份獎勵計劃及首次公開發售後購股權計劃的股份期權數目亦無變動，分別為3,665,141股和26,800,000股。公司確認，所有證券的發行均已獲得董事會的正式授權批准，並符合相關法律規定。
维亚生物科技控股於2024年4月3日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的公司股本變動情況。報告顯示，公司的法定/註冊股本及已發行股份在過去一個月內均無變動，普通股股份數目維持在4,000,000,000股，每股面值0.000025美元，總法定/註冊股本為100,000美元。此外，公司的股份期權計劃中，首次公開發售前股份獎勵計劃及首次公開發售後購股權計劃的股份期權數目亦無變動，分別為3,665,141股和26,800,000股。公司確認，所有證券的發行均已獲得董事會的正式授權批准，並符合相關法律規定。
VIA BIOTECH HOLDINGS FILED ITS LATEST MONTHLY SECURITIES CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON APRIL 3, 2024, REPORTING CHANGES IN THE COMPANY'S SHARE CAPITAL AS OF MARCH 31, 2024. The report shows that the company's regulary/registered share capital and issued shares were unchanged over the past month, and the number of ordinary shares remained at 4,000,000,000 shares with a face value of $0.000025 per share and a total regulated/registered share capital of $100,000. In addition, the number of stock options under the Initial Public Offering Share Award Scheme and the Initial Public Offering Post-IPO Share Option Scheme remained unchanged at 3,665,141 shares and 26,800,000 shares, respectively. The Company confirms that all issuances of securities have been formally authorized by the Board of Directors and comply with the relevant legal requirements.
VIA BIOTECH HOLDINGS FILED ITS LATEST MONTHLY SECURITIES CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON APRIL 3, 2024, REPORTING CHANGES IN THE COMPANY'S SHARE CAPITAL AS OF MARCH 31, 2024. The report shows that the company's regulary/registered share capital and issued shares were unchanged over the past month, and the number of ordinary shares remained at 4,000,000,000 shares with a face value of $0.000025 per share and a total regulated/registered share capital of $100,000. In addition, the number of stock options under the Initial Public Offering Share Award Scheme and the Initial Public Offering Post-IPO Share Option Scheme remained unchanged at 3,665,141 shares and 26,800,000 shares, respectively. The Company confirms that all issuances of securities have been formally authorized by the Board of Directors and comply with the relevant legal requirements.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more